FDA Approves Sanofi’s Rapid Acting Insulin Biosimilar Merilog for Diabetes Posted on February 18, 2025February 18, 2025 by admin Meilog marks the first rapid-acting insulin biosimilar to gain FDA approval for the treatment of diabetes.
